CAROLINA PAVON: Open Payments
NPI 1053951996 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 14 payments from 11 companies in 2025. Trend: 2023 $786 · 2024 $768 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $250 |
| Lilly USA, LLC | 2 | $247 |
| Insmed, Inc. | 2 | $240 |
| Astellas Pharma US Inc | 1 | $140 |
| Amgen Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $120 |
| PFIZER INC. | 1 | $100 |
| Boston Scientific Corporation | 1 | $89 |
Products named: CAPLYTA, Arikayce, Veozah, OTEZLA, VRAYLAR, KISUNLA, JARDIANCE, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
